NCT03687242 · Interventional trial
Study to Evaluate the Safety and Efficacy of SPR001 in Subjects With Classic Congenital Adrenal Hyperplasia
Overall registry status Completed
Phase 2
Conditions CAH - 21-Hydroxylase Deficiency, CAH - Congenital Adrenal Hyperplasia, Congenital Adrenal Hyperplasia
Delaware Valley sites
- Spruce Biosciences Clinical Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory